DogVerm plus 20 / 200 tablets, dewormer for dogs - Drontal alternative but better

DogVerm plus 20 / 200 tablets, dewormer for dogs - Drontal alternative but better - Pet Shop Luna

Pet Shop Luna

$21.95 

Dogverm Plus tablets for dogs A.U.V. was manufactured to treat dog infections with intestinal worms.

NAME AND ADDRESS OF THE MARKETING AUTHORIZATION HOLDER RESPONSIBLE FOR BATCH RELEASE AND MANUFACTURING AUTHORIZATION HOLDER RESPONSIBLE FOR BATCH RELEASE

The marketing authorization holder:

Tolnagro Állatgyógyászati ​​Kft.

7100 Szekszárd, Rákóczi u. 142-146.

Manufacturer responsible for batch release:

Pernix Pharma Gyógyszergyártó Kft.
8900 Zalaegerszeg, Eszaki lparterület,
Camilla u. 3.

METHOD OF APPLICATION

Dogverm Plus tablets for dogs A. U. V.

1. Product name

Dogverm Plus tablets for dogs A.U.V.

2. Product composition and ingredients

1 tablet contains:

Active substances:
Praziquantel 50 mg
Pirantel embonat 144 mg
Fenbendazole 200 mg
Excipients 700 mg

3. Recommendations

It is recommended to use the product in case of infections of dogs with intestinal worms. The result of the combination of active substances is a broad-spectrum anthelmintic, which is effective against roundworm species:

Earthworms: Toxocara canis, Toxascaris leonina (mature and immature intestinal worms in development)
Hookworms: Ancylostoma caninum, Uncinaria slenocephala (mature worms)
Bike worms: Trichuris vulpis (mature worms)
Tapeworms: Dipylidium caninum, Taenia spp., Echinacoccus granulosus (adult worms and developmental stages untouched)
4. Contraindications

It cannot be applied if the animal is sensitive to the active substances or ingredients of the product. It cannot be applied with another antiparasitic product containing piperazine derivatives and / or organic phosphate esters.

5. Side effects

The following side effects may rarely occur: loss of appetite, diarrhea, vomiting, weakness, or temporary increase in AST (aspartate aminotransferase).
If you notice any other serious side effects not listed in this leaflet, please consult your veterinarian without delay.

6. Target animals
Dog

7. Dosage, method of administration for target animals
Method of administration:
Orally only.

Dosage: 1 tablet / 10 kg body weight.
For general deworming, a single administration is sufficient. If intestinal worm infection has been diagnosed, then treatment should be repeated after 14 days.

Dog body weight (kg) Tablet quantity (piece)
Puppies and small dogs
2-5 1/2
6-10 1
Medium sized dogs
11-20 2
21-30 3
Large dogs
31-40 4
8. Correct administration recommendations

The tablets can be taken directly into the animal's mouth or into the animal's food. There is no need to starve the animal during treatment.

9. Waiting time
It is not necessary.

10. Special storage recommendations
Store in a cool, dry place, away from direct sunlight, below 25 ° C.
Keep out of reach of children!
Expiration time: 3 years.
After unpacking the tablet, the expiration time changes to: 3 months.

11. Special warnings

Special warnings apply to all target animals:
Pyrantel-containing medicines can be administered with caution to animals. Fleas are intermediate hosts of the tapeworm of the common genus Dipylidium caninum. The tapeworm infection can recur if the intermediate hosts - fleas, mice - are not destroyed. Anthelmintic tolerance may occur as a result of repeated treatments with anthelmintics belonging to the same group.

Special warnings for target animals:
Animals should be kept closed for 24 hours from tablet administration, and feces, worms and eggs should be burned. Regular cleaning and disinfection of places where the animal spends a lot of time and of beds is recommended.

Special warnings for the person administering the product:
If swallowed accidentally, you should consult your doctor without delay, with the package leaflet or at least the removal of the product. In case of sensitivity to the ingredients of the product it is recommended to avoid contact with the product. After administration, wash your hands thoroughly with water. The baby should be kept away from the animal for treatment for several days after administration of the product.

Administration during pregnancy, lactation:
The safety of the veterinary product was not verified in the first 2 trimesters of pregnancy, nor during lactation.

It can only be given after the veterinarian has performed the risk analysis.

Interactions with other drugs:

Due to the antagonism between the basic compounds pírarrtel and the active ingredients, the product cannot be administered with other piperazine-containing medicines. It also cannot be administered together with the organic esters of phosphoric acid and diethylcarbamazine. Due to the mechanism of action of pyrantel and the peculiarities of toxicity, the productit should not be administered concomitantly with morantel or its combinations. The pharmacokinetics of praziquantel are significantly influenced by glucocorticoids, antiepileptics, therefore concomitant administration should be considered.

Overdose (symptoms, antidotes, emergency measures):
The product does not cause side effects if the dose is given 3-5 times higher than the recommended one, nor at the 3rd repetition with this dose.

Incompatibilities:
They don't know each other.

12. Instructions for the unconsumed product or its waste (if required)
The veterinary product must not end up in wastewater or household waste.
Any unused veterinary medicinal product and waste materials should be disposed of in accordance with local requirements.

13. Date of approval of the user manual
December 21st. 2015.

14. Other information:
If you have further questions regarding the veterinary product, you can contact the dealer:

Tolnagro Állatgyógyászati ​​Kft.
7100 Szekszárd, Rákóczi u. 142-146.
Phone: +36 74 / 528-528
Fax: +36 74 / 528-530
E-mail: info@tolnagro.hu

14.1. Ordering conditions
Veterinary medical product, prescription only. For veterinary use only.

14.2 Marketability

Only those with authorization are entitled to the distribution of veterinary medicinal products.

14.3. Packing:

2x10 tablets in blisters.
200 tablets in polyethylene container.

15.4.Marketing authorization numbers
3496/1/14 NÉBIH ÁTI (2x10 tablet)
3496/2/14 NÉBIH ÁTI (200 tablets)